850146-80-4 Usage
General Description
Methyl 2-hydroxy-5-iodo-4-methylbenzoate is a chemical compound with the molecular formula C9H9IO3. It is a derivative of benzoic acid and belongs to the class of esters. methyl 2-hydroxy-5-iodo-4-methylbenzoate is characterized by the presence of a hydroxyl group, a methyl group, and an iodine atom attached to a benzene ring. Methyl 2-hydroxy-5-iodo-4-methylbenzoate has potential uses in organic synthesis and pharmaceutical research due to its structural features and reactivity. It is important to handle this compound with caution and follow proper safety protocols when working with it in a laboratory setting.
Check Digit Verification of cas no
The CAS Registry Mumber 850146-80-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,0,1,4 and 6 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 850146-80:
(8*8)+(7*5)+(6*0)+(5*1)+(4*4)+(3*6)+(2*8)+(1*0)=154
154 % 10 = 4
So 850146-80-4 is a valid CAS Registry Number.
850146-80-4Relevant articles and documents
Total Synthesis of (±)-Phaeocaulisin D
Ezzat, Nameer,Bobek, Katelyn,Yuan, Yu
, p. 689 - 692 (2021)
The tropone sesquiterpene phaeocaulisin D, isolated from the rhizomes of Curcuma phaeocaulis, has previously been shown to inhibit nitric oxide production in macrophages. A total synthesis of phaeocaulisin D was accomplished by using an intramolecular cyc
APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS AND USES THEREOF
-
Paragraph 00396, (2019/04/09)
Described herein are ASK1 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of blood disease, autoimmune disorders, pulmonary disorders, hypertension, inflammatory diseases, fibrotic diseases, diabetes, diabetic nephropathy, renal diseases, respiratory diseases, cardiovascular diseases, acute lung injuries, acute or chronic liver diseases, and neurodegenerative diseases.
